Atoptix LLC, formed out of research at Penn State University, develops imaging and spectroscopy platforms for advancing applications in biochemical sensing, health monitoring, and other applications. The company's primary technology is the G-Fresnel Cell-Phone Spectrometer, a compact and affordable device with applications such as breast cancer detection, monitoring surgical wounds and color analysis for assisting people with color blindness.
